Copyright reuters
CompaniesKoninklijke Philips NV Nov 4 (Reuters) - Dutch medical technology company Philips (PHG.AS), opens new tab reported third-quarter revenue in line with analysts' expectations on Tuesday, citing a strong performance in North America. The company posted a 3% rise in sales to 4.3 billion euros ($5.0 billion), matching analysts' average estimate in a company-compiled poll. Philips, which makes the biggest share of its revenue in the United States, flagged last quarter that tariffs would have a lower impact than expected following a trade agreement between the EU and United States. Advertisement · Scroll to continueReport Ad Its adjusted earnings before interest, tax and amortisation (EBITA) came in at 531 million euros, surpassing the 484 million expected by analysts. CEO Roy Jakobs said in a call with reporters that the performance reflected investments it had made in its supply chain to mitigate tariff impacts in the United States and China. "At the same time, we keep advocating that actually every dollar, euro, RMB spent on tariffs is not spent on patients. And actually healthcare is under enough pressure that they don't need additional pressure from tariffs," he added. Philips reiterated its full year sales and earnings guidance. Advertisement · Scroll to continue Get the key points from this story with Reuters AI ($1 = 0.8575 euros) Ad Break Coming Up NEXT StayNext OffEnglish 180p288p360p480p540p576p720pHD1080pHDAuto (180p) About ConnatixV2137053060 About ConnatixV2137053060 Continue watchingafter the adVisit Advertiser websiteGO TO PAGE Reporting by Leo Marchandon in Gdansk, editing by Milla Nissi-Prussak and Matt Scuffham Purchase Licensing Rights Leo MarchandonThomson ReutersLeo is a news reporter based in Gdansk, focusing on the media, telecoms, and technology sectors in France and the Benelux countries. Prior to this, he worked in France, covering regional and business news, including politics, policies, economy and business with strong focus on tech startups.Email
